Company / Cost of Revenue
PRECIGEN, INC. Cost of Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$33.3M
FY2017
5-year range
-
FY2016-FY2017
Trend
-11.8%
vs FY2016
Sector context
#59 of 85
Health Care
What the data says
At $33M, PRECIGEN, INC.'s cost of revenue ranks #27 of 85 in the Health Care sector.
Based on SEC 10-K filings.
$33M in FY2017.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#27 of 85 in Health CareTop 31% of 85This company $33.3M Sector average $2.0B
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2017, cost of revenue decreased 11.8% year-over-year.
- Ranks #59 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -14.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $33.3M | -11.8% |
| FY2016 | $37.7M | +171304.5% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026